Advances in CRISPR-Cas9 genome engineering: Lessons learned from RNA interference

Nucleic Acids Research

Volumn 43, Issue 7, 2015, Pages 3407-3419

  Barrangou, Rodolphe ^a   Birmingham, Amanda ^b   Wiemann, Stefan ^c   Beijersbergen, Roderick L ^d   Hornung, Veit ^e   Smith, Anja Van Brabant ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b Dharmacon Inc   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; MICRORNA; PATTERN RECOGNITION RECEPTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; VEMURAFENIB;

CRISPR CAS SYSTEM; CYTOKINE RESPONSE; DOUBLE STRANDED DNA BREAK; DRUG RESISTANCE; GENE CONTROL; GENE DISRUPTION; GENE SILENCING; GENE TARGETING; GENETIC ENGINEERING; GENETIC TRANSFECTION; HIGH THROUGHPUT SCREENING; INDEL MUTATION; INNATE IMMUNITY; MELANOMA CELL; NONHUMAN; PATENT; PRIORITY JOURNAL; REVIEW; RNA EDITING; RNA INTERFERENCE; ANIMAL; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENETICS; GENOME;

BACTERIA (MICROORGANISMS); MAMMALIA;

ANIMALS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; GENETIC ENGINEERING; GENOME; RNA INTERFERENCE;

EID: 84930503842     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv226     Document Type: Review

References (145)

1. Boutros, M. and Ahringer, J. (2008) The art and design of genetic screens: RNA interference. Nat. Rev. Genet., 9, 554-566.
2. Hsu, P.D., Lander, E.S. and Zhang, F. (2014) Development and applications of CRISPR-Cas9 for genome engineering. Cell, 157, 1262-1278.
3. Tripp, R.A. and Karpilow, J.M. (2014) Frontiers in RNAi. Bentham Science, Sharjah.
4. Sander, J.D. and Joung, J.K. (2014) CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol., 32, 347-355.
5. Zhang, F., Wen, Y. and Guo, X. (2014) CRISPR/Cas9 for genome editing: progress, implications and challenges. Hum. Mol. Genet., 23, R40-R46.
6. Ameres, S.L. and Zamore, P.D. (2013) Diversifying microRNA sequence and function. Nat. Rev. Mol. Cell Biol., 14, 475-488.
7. Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D.A. and Horvath, P. (2007) CRISPR provides acquired resistance against viruses in prokaryotes. Science, 315, 1709-1712.
8. Brouns, S.J., Jore, M.M., Lundgren, M., Westra, E.R., Slijkhuis, R.J., Snijders, A.P., Dickman, M.J., Makarova, K.S., Koonin, E.V. and van der Oost, J. (2008) Small CRISPR RNAs guide antiviral defense in prokaryotes. Science, 321, 960-964.
9. Marraffni, L.A. and Sontheimer, E.J. (2008) CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science, 322, 1843-1845.
10. Hale, C.R., Zhao, P., Olson, S., Duff, M.O., Graveley, B.R., Wells, L., Terns, R.M. and Terns, M.P. (2009) RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell, 139, 945-956.
11. Makarova, K.S., Haft, D.H., Barrangou, R., Brouns, S.J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F.J., Wolf, Y.I., Yakunin, A.F. et al. (2011) Evolution and classifcation of the CRISPR-Cas systems. Nat. Rev. Microbiol., 9, 467-477.
12. Deltcheva, E., Chylinski, K., Sharma, C.M., Gonzales, K., Chao, Y., Pirzada, Z.A., Eckert, M.R., Vogel, J. and Charpentier, E. (2011) CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature, 471, 602-607.
13. Garneau, J.E., Dupuis, M.E., Villion, M., Romero, D.A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadan, A.H. and Moineau, S. (2010) The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature, 468, 67-71.
14. Sapranauskas, R., Gasiunas, G., Fremaux, C., Barrangou, R., Horvath, P. and Siksnys, V. (2011) The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Res., 39, 9275-9282.
15. Gasiunas, G., Barrangou, R., Horvath, P. and Siksnys, V. (2012) Cas9-crRNA ribonucleoprotein complex mediates specifc DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. U. S.A., 109, E2579-E2586.
16. Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J.A. and Charpentier, E. (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 337, 816-821.
17. Horvath, P., Romero, D.A., Coute-Monvoisin, A.C., Richards, M., Deveau, H., Moineau, S., Boyaval, P., Fremaux, C. and Barrangou, R. (2008) Diversity, activity, and evolution of CRISPR loci in Streptococcus thermophilus. J. Bacteriol., 190, 1401-1412.
18. Deveau, H., Barrangou, R., Garneau, J.E., Labonte, J., Fremaux, C., Boyaval, P., Romero, D.A., Horvath, P. and Moineau, S. (2008) Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J. Bacteriol., 190, 1390-1400.
19. Mojica, F.J., Diez-Villasenor, C., Garcia-Martinez, J. and Almendros, C. (2009) Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology, 155, 733-740.
20. Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X., Jiang, W., Marraffni, L.A. et al. (2013) Multiplex genome engineering using CRISPR/Cas systems. Science, 339, 819-823.
21. Mali, P., Yang, L., Esvelt, K.M., Aach, J., Guell, M., DiCarlo, J.E., Norville, J.E. and Church, G.M. (2013) RNA-guided human genome engineering via Cas9. Science, 339, 823-826.
22. Jinek, M., East, A., Cheng, A., Lin, S., Ma, E. and Doudna, J. (2013)RNA-programmed genome editing in human cells. Elife, 2, 1-9.
23. Chapman, J.R., Taylor, M.R. and Boulton, S.J. (2012) Playing the end game: DNA double-strand break repair pathway choice. Mol. Cell, 47, 497-510.
24. Reynolds, A., Leake, D., Scaringe, S., Marshall, W.S., Boese, Q. and Khvorova, A. (2004) Rational siRNA design for RNA interference. Nat. Biotechnol., 22, 326-330.
25. Fu, Y., Foden, J.A., Khayter, C., Maeder, M.L., Reyon, D., Joung, J.K. and Sander, J.D. (2013) High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol., 31, 822-826.
26. Shalem, O., Sanjana, N.E., Hartenian, E., Shi, X., Scott, D.A., Mikkelsen, T.S., Heckl, D., Ebert, B.L., Root, D.E., Doench, J.G. et al. (2014) Genome-scale CRISPR-Cas9 knockout screening in human cells. Science, 343, 84-87.
27. Wang, T., Wei, J.J., Sabatini, D.M. and Lander, E.S. (2014) Genetic screens in human cells using the CRISPR-Cas9 system. Science, 343, 80-84.
28. Doench, J.G., Hartenian, E., Graham, D.B., Tothova, Z., Hegde, M., Smith, I., Sullender, M., Ebert, B.L., Xavier, R.J. and Root, D.E. (2014) Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat. Biotechnol., 32, 1262-1267.
29. Jinek, M., Jiang, F., Taylor, D.W., Sternberg, S.H., Kaya, E., Ma, E., Anders, C., Hauer, M., Zhou, K., Lin, S. et al. (2014) Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science, 343, 1247997.
30. Nishimasu, H., Ran, F.A., Hsu, P.D., Konermann, S., Shehata, S.I., Dohmae, N., Ishitani, R., Zhang, F. and Nureki, O. (2014) Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell, 156, 935-949.
31. Jackson, A., Bartz, S.R., Schelter, J., Kobayashi, S.V., Burchard, J., Mao, M., Li, B., Cavet, G. and Linsley, P.S. (2003) Expression profling reveals off-target gene regulation by RNAi. Nat. Biotechnol., 21, 635-637.
32. Jackson, A.L., Burchard, J., Leake, D., Reynolds, A., Schelter, J., Guo, J., Johnson, J.M., Lim, L., Karpilow, J., Nichols, K. et al. (2006) Position-specifc chemical modifcation of siRNAs reduces 'off-target' transcript silencing. RNA.12, 1197-1205.
33. Smith, C., Gore, A., Yan, W., Abalde-Atristain, L., Li, Z., He, C., Wang, Y., Brodsky, R.A., Zhang, K., Cheng, L. et al. (2014) Whole-genome sequencing analysis reveals high specifcity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs. Cell Stem Cell, 15, 12-13.
34. Veres, A., Gosis, B.S., Ding, Q., Collins, R., Ragavendran, A., Brand, H., Erdin, S., Talkowski, M.E. and Musunuru, K. (2014) Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. Cell Stem Cell, 15, 27-30.
35. Birmingham, A., Anderson, E.M., Reynolds, A., Ilsley-Tyree, D., Leake, D, Fedorov, Y, Baskerville, S., Maksimova, E., Robinson, K., Karpilow, J. et al. (2006) 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat. Methods, 3, 199-204.
36. Whitehurst, A.W., Bodemann, B.O., Cardenas, J., Ferguson, D., Girard, L., Peyton, M., Minna, J.D., Michnoff, C, Hao, W., Roth, M.G. et al. (2007) Synthetic lethal screen identifcation of chemosensitizer loci in cancer cells. Nature, 446, 815-819.
37. Berns, K., Hijmans, E., Mullenders, J., Brummelkamp, T., Velds, A., Heimerikx, M., Kerkhoven, R., Madiredjo, M., Nijkamp, W., Weigelt, B. et al. (2004) A large-scale RNAi screen in human cells identifes new components of the p53 pathway. Nature, 428, 431-437.
38. Yasue, A., Mitsui, S.N, Watanabe, T., Sakuma, T., Oyadomari, S., Yamamoto, T., Noji, S., Mito, T. and Tanaka, E. (2014) Highly effcient targeted mutagenesis in one-cell mouse embryos mediated by the TALEN and CRISPR/Cas systems. Sci. Rep., 4, 5705-5715.
39. Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E. and Mello, C.C. (1998) Potent and specifc genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391, 806-811.
40. Mojica, F.J., Diez-Villasenor, C, Soria, E. and Juez, G. (2000) Biological signifcance of a family of regularly spaced repeats in the genomes of Archaea, Bacteria and mitochondria. Mol. Microbiol., 36, 244-246.
41. Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K. and Tuschl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411, 494-498.
42. Jansen, R., Embden, J.D., Gaastra, W. and Schouls, L.M. (2002) Identifcation of genes that are associated with DNA repeats in prokaryotes. Mol. Microbiol, 43, 1565-1575.
43. Paddison, PJ., Caudy, A.A., Bernstein, E., Hannon, G.J. and Conklin, DS. (2002) Short hairpin RNAs (shRNAs) induce sequence-specifc silencing in mammalian cells. Genes Dev., 16, 948-958.
44. Song, E., Lee, S.K., Wang, J., Ince, N, Ouyang, N, Min, J., Chen, J., Shankar, P and Lieberman, J. (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med., 9, 347-351.
45. Makarova, K.S., Grishin, NV., Shabalina, S.A., Wolf, Y.I. and Koonin, E.V. (2006) A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol. Direct, 1, 7-35.
46. WangY, Juranek, S., Li, H., Sheng, G, Tuschl, T. and Patel, DJ. (2008) Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex. Nature, 456, 921-926.
47. Davis, M.E., Zuckerman, J.E., Choi, C.H., Seligson, D, Tolcher, A., Alabi, C.A., Yen, Y, Heidel, J.D. and Ribas, A. (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature, 464, 1067-1070.
48. Pourcel, C., Salvignol, G and Vergnaud, G (2005) CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology, 151, 653-663.
49. Mojica, F.J., Diez-Villasenor, C., Garcia-Martinez, J. and Soria, E. (2005) Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J. Mol. Evol., 60, 174-182.
50. Bolotin, A., Quinquis, B., Sorokin, A. and Ehrlich, S.D (2005) Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology, 151, 2551-2561.
51. Jiang, W., Bikard, D., Cox, D, Zhang, F. and Marraffni, L.A. (2013) RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol., 31, 233-239.
52. Barrangou, R. and Marraffni, L.A. (2014) CRISPR-Cas systems: prokaryotes upgrade to adaptive immunity. Mol. Cell, 54, 234-244.
53. Charpentier, E. and Marraffni, L.A. (2014) Harnessing CRISPR-Cas9 immunity for genetic engineering. Curr. Opin. Microbiol., 19, 114-119.
54. Doudna, J.A. and Charpentier, E. (2014) Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science, 346, 1258096.
55. van der Oost, J., Westra, E.R., Jackson, R.N. and Wiedenheft, B. (2014) Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat. Rev. Microbiol., 12, 479-492.
56. Westra, E.R., Buckling, A. and Fineran, P.C. (2014) CRISPR-Cas systems: beyond adaptive immunity. Nat. Rev. Microbiol., 12, 317-326.
57. Barrangou, R. and May, A.P. (2015) Unraveling the potential of CRISPR-Cas9 for gene therapy. Expert Opin. Biol. Ther., 15, 311-314.
58. Mohr, S.E., Smith, J.A., Shamu, C.E., Neumuller, R.A. and Perrimon, N. (2014) RNAi screening comes of age: improved techniques and complementary approaches. Nat. Rev. Mol. Cell Biol., 15, 591-600.
59. Echeverri, C.J. and Perrimon, N. (2006) High-throughput RNAi screening in cultured cells: a user's guide. Nat. Rev. Genet., 7, 373-384.
60. Taxman, D.J., Livingstone, L.R., Zhang, J., Conti, B.J., Iocca, H.A., Williams, K.L., Lich, J.D., Ting, J.P. and Reed, W. (2006) Criteria for effective design, construction, and gene knockdown by shRNA vectors. BMC Biotechnol., 6, 7-23.
61. Ebalunode, J.O., Jagun, C. and Zheng, W. (2011) Informatics approach to the rational design of siRNA libraries. Methods Mol. Biol., 672, 341-358.
62. Matveeva, O.V., Nazipova, N.N., Ogurtsov, A.Y. and Shabalina, S.A. (2012) Optimized models for design of effcient miR30-based shRNAs. Front. Genet., 3, 163.
63. Sternberg, S.H., Redding, S., Jinek, M., Greene, E.C. and Doudna, J.A. (2014) DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature, 507, 62-67.
64. Elbashir, S.M., Lendeckel, W. and Tuschl, T. (2001) RNA interference is mediated by 21-and 22-nucleotide RNAs. Genes Dev., 15, 188-200.
65. Birmingham, A., Kaufmann, A. and Kozak, K. (2014) RNAi and Off-Target Effects. In: Tripp, RA and Karpilow, JM (eds). Frontiers in RNAi. Bentham Science, Sharjah, 3-20.
66. Hornung, V., Guenthner-Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A., Manoharan, M., Akira, S., de Fougerolles, A. et al. (2005) Sequence-specifc potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med., 11, 263-270.
67. Marques, J.T., Devosse, T., Wang, D., Zamanian-Daryoush, M., Serbinowski, P., Hartmann, R., Fujita, T., Behlke, M.A. and Williams, B.R. (2006) A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat. Biotechnol., 24, 559-565.
68. Reynolds, A., Anderson, E.M., Vermeulen, A., Fedorov, Y., Robinson, K., Leake, D., Karpilow, J., Marshall, W.S. and Khvorova, A. (2006) Induction of the interferon response by siRNA is cell type-and duplex length-dependent. RNA, 12, 1-6.
69. Jacobsen, L., Calvin, S. and Lobenhofer, E. (2009) Transcriptional effects of transfection: the potential for misinterpretation of gene expression data generated from transiently transfected cells. Biotechniques, 47, 617-624.
70. Judge, A.D., Bola, G., Lee, A.C. and MacLachlan, I. (2006) Design of noninfammatory synthetic siRNA mediating potent gene silencing in vivo. Mol. Ther., 13, 494-505.
71. Morrissey, D.V., Lockridge, J.A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V. et al. (2005) Potent and persistent in vivo anti-HBV activity of chemically modifed siRNAs. Nat. Biotechnol., 23, 1002-1007.
72. Grimm, D., Streetz, K.L., Jopling, C.L., Storm, T.A., Pandey, K., Davis, C.R., Marion, P., Salazar, F. and Kay, M.A. (2006) Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature, 441, 537-541.
73. Pruett-Miller, S.M., Reading, D.W., Porter, S.N. and Porteus, M.H. (2009) Attenuation of zinc fnger nuclease toxicity by small-molecule regulation of protein levels. PLoS Genet., 5, e1000376.
74. Franceschini, A., Meier, R., Casanova, A., Kreibich, S., Daga, N., Andritschke, D., Dilling, S., Ramo, P., Emmenlauer, M., Kaufmann, A. et al. (2014) Specifc inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screens. Proc. Natl. Acad. Sci. U.S.A., 111, 4548-4553.
75. Cho, S.W., Kim, S., Kim, Y., Kweon, J., Kim, H.S., Bae, S. and Kim, J.S. (2014) Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Re., 24, 132-141.
76. Fu, Y., Sander, J.D., Reyon, D., Cascio, V.M. and Joung, J.K. (2014) Improving CRISPR-Cas nuclease specifcity using truncated guide RNAs. Nat. Biotechnol., 32, 279-284.
77. Ran, F.A., Hsu, P.D., Lin, C.Y., Gootenberg, J.S., Konermann, S., Trevino, A.E., Scott, D.A., Inoue, A., Matoba, S., Zhang, Y. et al. (2013) Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specifcity. Cell, 154, 1380-1389.
78. Shen, B., Zhang, W., Zhang, J., Zhou, J., Wang, J., Chen, L., Wang, L., Hodgkins, A., Iyer, V., Huang, X. et al. (2014) Effcient genome modifcation by CRISPR-Cas9 nickase with minimal off-target effects. Nat. Methods, 11, 399-402.
79. Lin, Y., Cradick, T.J., Brown, M.T., Deshmukh, H., Ranjan, P., Sarode, N., Wile, B.M., Vertino, P.M., Stewart, F.J. and Bao, G. (2014) CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences. Nucleic Acids Res., 42, 7473-7485.
80. Tsai, S.Q., Wyvekens, N., Khayter, C., Foden, J.A., Thapar, V., Reyon, D., Goodwin, M.J., Aryee, M.J. and Joung, J.K. (2014) Dimeric CRISPR RNA-guided FokI nucleases for highly specifc genome editing. Nat. Biotechnol., 32, 569-576.
81. Hsu, P.D., Scott, D.A., Weinstein, J.A., Ran, F.A., Konermann, S., Agarwala, V., Li, Y., Fine, E.J., Wu, X., Shalem, O. et al. (2013) DNA targeting specifcity of RNA-guided Cas9 nucleases. Nat. Biotechnol., 31, 827-832.
82. Birmingham, A., Selfors, L.M., Forster, T., Wrobel, D., Kennedy, C.J., Shanks, E., Santoyo-Lopez, J., Dunican, D.J., Long, A., Kelleher, D. et al. (2009) Statistical methods for analysis of high-throughput RNA interference screens. Nat. Methods, 6, 569-575.
83. Maresca, M., Lin, V.G., Guo, N. and Yang, Y. (2013) Obligate ligation-gated recombination (ObLiGaRe): custom-designed nuclease-mediated targeted integration through nonhomologous end joining. Genome Res., 23, 539-546.
84. Kranz, D. and Boutros, M. (2014) A synthetic lethal screen identifes FAT1 as an antagonist of caspase-8 in extrinsic apoptosis. EMBO J., 33, 181-197.
85. Rodriguez-Barrueco, R., Marshall, N. and Silva, J.M. (2013) Pooled shRNA screenings: experimental approach. Methods Mol. Biol., 980, 353-370.
86. Zhou, Y., Zhu, S., Cai, C., Yuan, P., Li, C., Huang, Y. and Wei, W. (2014) High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells. Nature, 509, 487-491.
87. Koike-Yusa, H., Li, Y., Tan, E.P., Velasco-Herrera Mdel, C. and Yusa, K. (2014) Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat. Biotechnol., 32, 267-273.
88. Schlabach, M.R., Luo, J., Solimini, N.L., Hu, G., Xu, Q., Li, M.Z., Zhao, Z., Smogorzewska, A., Sowa, M.E., Ang, X.L. et al. (2008) Cancer proliferation gene discovery through functional genomics. Science, 319, 620-624.
89. Kolfschoten, I., van Leeuwen, B., Berns, K., Mullenders, J., Beijersbergen, R., Bernards, R., Voorhoeve, P. and Agami, R. (2005) A genetic screen identifes PITX1 as a suppressor of RAS activity and tumorigenicity. Cell, 121, 849-858.
90. Brummelkamp, T.R., Fabius, A.W., Mullenders, J., Madiredjo, M., Velds, A., Kerkhoven, R.M., Bernards, R. and Beijersbergen, R.L. (2006) An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors. Nat. Chem. Biol., 2, 202-206.
91. Moffat, J., Grueneberg, D.A., Yang, X., Kim, S.Y., Kloepfer, A.M., Hinkle, G., Piqani, B., Eisenhaure, T.M., Luo, B., Grenier, J.K. et al. (2006) A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell, 124, 1283-1298.
92. Fellmann, C., Zuber, J., McJunkin, K., Chang, K., Malone, C.D., Dickins, R.A., Xu, Q., Hengartner, M.O., Elledge, S.J., Hannon, G.J. et al. (2011) Functional identifcation of optimized RNAi triggers using a massively sensor assay. Molecular cell, 41, 733-746.
93. Buehler, E., Chen, Y.C. and Martin, S. (2012) C911: a bench-level control for sequence specifc siRNA off-target effects. PloS One, 7, e51942.
94. Hart, T., Brown, K.R., Sircoulomb, F., Rottapel, R. and Moffat, J. (2014) Measuring error rates in genomic perturbation screens: gold standards for human functional genomics. Mol. Syst. Biol., 10, 733-754.
95. Sun, C., Wang, L., Huang, S., Heynen, G.J., Prahallad, A., Robert, C., Haanen, J., Blank, C., Wesseling, J., Willems, S.M. et al. (2014) Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma. Nature, 508, 118-122.
96. Wang, H., Yang, H., Shivalila, C.S., Dawlaty, M.M., Cheng, A.W., Zhang, F. and Jaenisch, R. (2013) One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell, 153, 910-918.
97. Xue, W., Chen, S., Yin, H., Tammela, T., Papagiannakopoulos, T., Joshi, N.S., Cai, W., Yang, G., Bronson, R., Crowley, D.G. et al. (2014) CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature.514, 380-384.
98. Heckl, D., Kowalczyk, M.S., Yudovich, D., Belizaire, R., Puram, R.V., McConkey, M.E., Thielke, A., Aster, J.C., Regev, A. and Ebert, B.L. (2014) Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing. Nat. Biotechnol., 32, 941-946.
99. Fujii, W., Kawasaki, K., Sugiura, K. and Naito, K. (2013) Effcient generation of large-scale genome-modifed mice using gRNA and CAS9 endonuclease. Nucleic Acids Res., 41, e187.
100. Torres, R., Martin, M.C., Garcia, A., Cigudosa, J.C., Ramirez, J.C. and Rodriguez-Perales, S. (2014) Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system. Nat. Commun., 5, 3964-3966.
101. Ghezraoui, H., Piganeau, M., Renouf, B., Renaud, J.B., Sallmyr, A., Ruis, B., Oh, S., Tomkinson, A.E., Hendrickson, E.A., Giovannangeli, C. et al. (2014) Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining. Mol. Cell, 55, 829-842.
102. Deng, Y., Wang, C.C., Choy, K.W., Du, Q., Chen, J., Wang, Q., Li, L., Chung, T.K. and Tang, T. (2014) Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies. Gene, 538, 217-227.
103. Burnett, J.C. and Rossi, J.J. (2012) RNA-based therapeutics: current progress and future prospects. Chem. Biol., 19, 60-71.
104. Dong, Y., Love, K.T., Dorkin, J.R., Sirirungruang, S., Zhang, Y., Chen, D., Bogorad, R.L., Yin, H., Chen, Y., Vegas, A.J. et al. (2014) Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates. Proc. Natl. Acad. Sci. U.S.A., 111, 3955-3960.
105. Dahlman, J.E., Barnes, C., Khan, O.F., Thiriot, A., Jhunjunwala, S., Shaw, T.E., Xing, Y., Sager, H.B., Sahay, G., Speciner, L. et al. (2014) In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight. Nat. Nanotechnol., 9, 648-655.
106. Xie, F., Ye, L., Chang, J.C., Beyer, A.I., Wang, J., Muench, M.O. and Kan, Y.W. (2014) Seamless gene correction of beta-thalassemia mutations in patient-specifc iPSCs using CRISPR/Cas9 and piggyBac. Genome Res., 24, 1526-1533.
107. Yin, H., Xue, W., Chen, S., Bogorad, R.L., Benedetti, E., Grompe, M., Koteliansky, V., Sharp, P.A., Jacks, T. and Anderson, D.G. (2014) Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat. Biotechnol., 32, 551-553.
108. Wu, Y., Liang, D., Wang, Y., Bai, M., Tang, W., Bao, S., Yan, Z., Li, D. and Li, J. (2013) Correction of a genetic disease in mouse via use of CRISPR-Cas9. Cell Stem Cell, 13, 659-662.
109. Schwank, G., Koo, B.K., Sasselli, V., Dekkers, J.F., Heo, I., Demircan, T., Sasaki, N., Boymans, S., Cuppen, E., van der Ent, C.K. et al. (2013) Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fbrosis patients. Cell Stem Ccell, 13, 653-658.
110. Zhen, S., Hua, L., Takahashi, Y., Narita, S., Liu, Y.H. and Li, Y. (2014) In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9. Biochem. Biophys. Res. Commun., 450, 1422-1426.
111. Ye, L., Wang, J., Beyer, A.I., Teque, F., Cradick, T.J., Qi, Z., Chang, J.C., Bao, G., Muench, M.O., Yu, J. et al. (2014) Seamless modifcation of wild-type induced pluripotent stem cells to the natural CCR5Delta32 mutation confers resistance to HIV infection. Proc. Natl. Acad. Sci. U.S.A., 111, 9591-9596.
112. Hu, W., Kaminski, R., Yang, F., Zhang, Y., Cosentino, L., Li, F., Luo, B., Alvarez-Carbonell, D., Garcia-Mesa, Y., Karn, J. et al. (2014) RNA-directed gene editing specifcally eradicates latent and prevents new HIV-1 infection. Proc. Natl. Acad. Sci. U.S.A., 111, 11461-11466.
113. Wagner, J.C., Platt, R.J., Goldfess, S.J., Zhang, F. and Niles, J.C. (2014) Effcient CRISPR-Cas9-mediated genome editing in Plasmodium falciparum. Nat. Methods, 11, 915-918.
114. Long, C., McAnally, J.R., Shelton, J.M., Mireault, A.A., Bassel-Duby, R. and Olson, E.N. (2014) Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA. Science, 345, 1184-1188.
115. Wang, J. and Quake, S.R. (2014) RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection. Proc. Natl. Acad. Sci. U.S.A., 111, 13157-13162.
116. Zuris, J.A., Thompson, D.B., Shu, Y., Guilinger, J.P., Bessen, J.L., Hu, J.H., Maeder, M.L., Joung, J.K., Chen, Z.Y. and Liu, D.R. (2014) Cationic lipid-mediated delivery of proteins enables effcient protein-based genome editing in vitro and in vivo. Nat. Biotechnol., 33, 73-80.
117. Sheridan, C. (2014) First CRISPR-Cas patent opens race to stake out intellectual property. Nat. Biotechnol., 32, 599-601.
118. Fennell, M., Xiang, Q., Hwang, A., Chen, C., Huang, C.H., Chen, C.C., Pelossof, R. and Garippa, R.J. (2014) Impact of RNA-guided technologies for target identifcation and deconvolution. J. Biomol. Screen., 19, 1327-1337.
119. Hansen, T.B., Jensen, T.I., Clausen, B.H., Bramsen, J.B., Finsen, B., Damgaard, C.K. and Kjems, J. (2013) Natural RNA circles function as effcient microRNA sponges. Nature, 495, 384-388.
120. Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., Maier, L., Mackowiak, S.D., Gregersen, L.H., Munschauer, M. et al. (2013) Circular RNAs are a large class of animal RNAs with regulatory potency. Nature, 495, 333-338.
121. Kasap, C., Elemento, O. and Kapoor, T.M. (2014) DrugTargetSeqR: a genomics-and CRISPR-Cas9-based method to analyze drug targets. Nat. Chem. Biol., 10, 626-628.
122. Lambeth, L.S. and Smith, C.A. (2013) Short hairpin RNA-mediated gene silencing. Methods Mol. Biol., 942, 205-232.
123. Bos, T.J., De Bruyne, E., Heirman, C. and Vanderkerken, K. (2009) In search of the most suitable lentiviral shRNA system. Curr. Gene Ther., 9, 192-211.
124. Qi, L.S., Larson, M.H., Gilbert, L.A., Doudna, J.A., Weissman, J.S., Arkin, A.P. and Lim, W.A. (2013) Repurposing CRISPR as an RNA-guided platform for sequence-specifc control of gene expression. Cell, 152, 1173-1183.
125. Bassett, A.R., Azzam, G., Wheatley, L., Tibbit, C., Rajakumar, T., McGowan, S., Stanger, N., Ewels, P.A., Taylor, S., Ponting, C.P. et al. (2014) Understanding functional miRNA-target interactions in vivo by site-specifc genome engineering. Nat. Commun., 5, 4640-4651.
126. Ji, P., Diederichs, S., Wang, W., Boing, S., Metzger, R., Schneider, P.M., Tidow, N., Brandt, B., Buerger, H., Bulk, E. et al. (2003) MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene, 22, 8031-8041.
127. Brown, C.J., Hendrich, B.D., Rupert, J.L., Lafreniere, R.G., Xing, Y., Lawrence, J. and Willard, H.F. (1992) The human XIST gene: analysis of a 17 kb inactive X-specifc RNA that contains conserved repeats and is highly localized within the nucleus. Cell, 71, 527-542.
128. Zeng, Y. and Cullen, B.R. (2002) RNA interference in human cells is restricted to the cytoplasm. RNA, 8, 855-860.
129. Han, J., Zhang, J., Chen, L., Shen, B., Zhou, J., Hu, B., Du, Y., Tate, P.H., Huang, X. and Zhang, W. (2014) Effcient in vivo deletion of a large imprinted lncRNA by CRISPR/Cas9. RNA Biol., 11, 829-835.
130. Cheng, A.W., Wang, H., Yang, H., Shi, L., Katz, Y., Theunissen, T.W., Rangarajan, S., Shivalila, C.S., Dadon, D.B. and Jaenisch, R. (2013) Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res., 23, 1163-1171.
131. Gilbert, L.A., Larson, M.H., Morsut, L., Liu, Z., Brar, G.A., Torres, S.E., Stern-Ginossar, N., Brandman, O., Whitehead, E.H., Doudna, J.A. et al. (2013) CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell, 154, 442-451.
132. Larson, M.H., Gilbert, L.A., Wang, X., Lim, W.A., Weissman, J.S. and Qi, L.S. (2013) CRISPR interference (CRISPRi) for sequence-specifc control of gene expression. Nat. Protoc., 8, 2180-2196.
133. Hu, J., Lei, Y., Wong, W.K., Liu, S., Lee, K.C., He, X., You, W., Zhou, R., Guo, J.T., Chen, X. et al. (2014) Direct activation of human and mouse Oct4 genes using engineered TALE and Cas9 transcription factors. Nucleic Acids Res., 42, 4375-4390.
134. Maeder, M.L., Linder, S.J., Cascio, V.M., Fu, Y., Ho, Q.H. and Joung, J.K. (2013) CRISPR RNA-guided activation of endogenous human genes. Nat. Methods, 10, 977-979.
135. Gilbert, L.A., Horlbeck, M.A., Adamson, B., Villalta, J.E., Chen, Y., Whitehead, E.H., Guimaraes, C., Panning, B., Ploegh, H.L., Bassik, M.C. et al. (2014) Genome-scale CRISPR-mediated control of gene repression and activation. Cell, 159, 647-661.
136. Konermann, S., Brigham, M.D., Trevino, A.E., Joung, J., Abudayyeh, O.O., Barcena, C., Hsu, P.D., Habib, N., Gootenberg, J.S., Nishimasu, H. et al. (2015) Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature, 517, 583-588.
137. Guo, D., Barry, L., Lin, S.S., Huang, V. and Li, L.C. (2014) RNAa in action: from the exception to the norm. RNA Biol., 11, 1221-1225.
138. Stephens, P.J., Greenman, C.D., Fu, B., Yang, F., Bignell, G.R., Mudie, L.J., Pleasance, E.D., Lau, K.W., Beare, D., Stebbings, L.A. et al. (2011) Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell, 144, 27-40.
139. Jiao, Y., Wickett, N.J., Ayyampalayam, S., Chanderbali, A.S., Landherr, L., Ralph, P.E., Tomsho, L.P., Hu, Y., Liang, H., Soltis, P.S. et al. (2011) Ancestral polyploidy in seed plants and angiosperms. Nature, 473, 97-100.
140. Wang, Y., Cheng, X., Shan, Q., Zhang, Y., Liu, J., Gao, C. and Qiu, J.-L. (2014) Simultaneous editing of three homoeoalleles in hexaploid bread wheat confers heritable resistance to powdery mildew. Nat. Biotechnol., 32, 947-951.
141. Findlay, G.M., Boyle, E.A., Hause, R.J., Klein, J.C. and Shendure, J. (2014) Saturation editing of genomic regions by multiplex homology-directed repair. Nature, 513, 120-123.
142. Yang, H., Wang, H., Shivalila, C.S., Cheng, A.W., Shi, L. and Jaenisch, R. (2013) One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell, 154, 1370-1379.
143. Grassian, A.R., Parker, S.J., Davidson, S.M., Divakaruni, A.S., Green, C.R., Zhang, X., Slocum, K.L., Pu, M., Lin, F., Vickers, C. et al. (2014) IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism. Cancer Res., 74, 3317-3331.
144. Maggio, I., Holkers, M., Liu, J., Janssen, J.M., Chen, X. and Goncalves, M.A. (2014) Adenoviral vector delivery of RNA-guided CRISPR/Cas9 nuclease complexes induces targeted mutagenesis in a diverse array of human cells. Sci. Rep., 4, 5105-5116.
145. Briner, A., Donohoue, P., Gomaa, A., Selle, K., Slorach, E., Nye, C., Haurwitz, R., Beisel, C., May, A. and Barrangou, R. (2014) Guide RNA functional modules direct Cas9 activity and orthogonality. Mol. Cell, 56, 333-339.